Eicosapentaenoic acid-enriched phospholipids improve Aβ1-40-induced cognitive deficiency in a rat model of Alzheimer's disease

Journal of Functional Foods

Volumn 24, Issue , 2016, Pages 537-548

  Wen, Min ^a   Xu, Jie ^a   Ding, Lin ^a   Zhang, Lingyu ^a   Du, Lei ^b   Wang, Jingfeng ^a   Wang, Yuming ^a   Xue, Changhu ^a  

^a OCEAN UNIVERSITY OF CHINA   (China)

^b HOKKAIDO UNIVERSITY   (Japan)

Author keywords

Alzheimer's disease; Apoptosis; A 1 40; EPA PLs; Hyperphosphorylated tau; Inflammation

Indexed keywords

EID: 84967020010     PISSN: 17564646     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jff.2016.04.034     Document Type: Article

References (69)

1. Ames B.N. Assay of inorganic phosphate, total phosphate and phosphatase. Methods in Enzymology 1966, 8:115-118.
2. Behl C., Moosmann B. Antioxidant neuroprotection in Alzheimer's disease as preventive and therapeutic approach. Free Radical Biology & Medicine 2002, 33(2):182-191. http://www.ncbi.nlm.nih.gov/pubmed/12106814.
3. Benveniste E.N., Tang L.P., Law R.M. Differential regulation of astrocyte TNF-alpha expression by the cytokines TGF-beta, IL-6 and IL-10. International Journal of Developmental Neuroscience 1995, 13(3-4):341-349. http://www.ncbi.nlm.nih.gov/pubmed/7572286.
4. Browning L.M. n-3 Polyunsaturated fatty acids, inflammation and obesity-related disease. The Proceedings of the Nutrition Society 2003, 62(2):447-453. http://www.ncbi.nlm.nih.gov/pubmed/14506893.
5. Bunea R., El Farrah K., Deutsch L. Evaluation of the effects of Neptune Krill Oil on the clinical course of hyperlipidemia. Alternative Medicine Review: A Journal of Clinical Therapeutic 2004, 9(4):420-428. http://www.ncbi.nlm.nih.gov/pubmed/15656713.
6. Cai Z., Zhao Y., Zhao B. Roles of glycogen synthase kinase 3 in Alzheimer's disease. Current Alzheimer Research 2012, 9(7):864-879. http://www.ncbi.nlm.nih.gov/pubmed/22272620.
7. Calder P.C. Omega 3 polyunsaturated fatty acids, inflammation and immunity. World Review of Nutrition and Dietetics 2001, 88:109-116. http://www.ncbi.nlm.nih.gov/pubmed/11935943.
8. Calon F., Lim G.P., Yang F., Morihara T., Teter B., Ubeda O., Rostaing P., Triller A., Salem N., Ashe K.H., Frautschy S.A., Cole G.M. Docosahexaenoic acid protects from dendritic pathology in an Alzheimer's disease mouse model. Neuron 2004, 43(5):633-645. 10.1016/j.neuron.2004.08.013.
9. Cederholm T., Salem N., Palmblad J. Omega-3 fatty acids in the prevention of cognitive decline in humans. Advances in Nutrition 2013, 4(6):672-676. 10.3945/an.113.004556.
10. Denis I., Potier B., Heberden C., Vancassel S. Omega-3 polyunsaturated fatty acids and brain aging. Current Opinion in Clinical Nutrition and Metabolic Care 2015, 18(2):139-146. 10.1097/MCO.0000000000000141.
11. Dickson D.W., Lee S.C., Mattiace L.A., Yen S.H., Brosnan C. Microglia and cytokines in neurological disease, with special reference to AIDS and Alzheimer's disease. Glia 1993, 7(1):75-83. 10.1002/glia.440070113.
12. Ding N., Xue Y., Tang X., Sun Z.M., Yanagita T., Xue C.H., Wang Y.M. Short-term effects of different fish oil formulations on tissue absorption of docosahexaenoic acid in mice fed high- and low-fat diets. Journal of Oleo Science 2013, 62(11):883-891. 10.5650/jos.62.883.
13. Dyall S.C., Michael G.J., Michael-Titus A.T. Omega-3 fatty acids reverse age-related decreases in nuclear receptors and increase neurogenesis in old rats. Journal of Neuroscience Research 2010, 88(10):2091-2102. 10.1002/jnr.22390.
14. Dyall S.C., Michael-Titus A.T. Neurological benefits of omega-3 fatty acids. Neuromolecular Medicine 2008, 10(4):219-235. 10.1007/s12017-008-8036-z.
15. Engel T., Hernandez F., Avila J., Lucas J.J. Full reversal of Alzheimer's disease-like phenotype in a mouse model with conditional overexpression of glycogen synthase kinase-3. Journal of Neuroscience 2006, 26(19):5083-5090. 10.1523/JNEUROSCI.0604-06.2006.
16. Fisher M., Levine P.H., Weiner B.H., Johnson M.H., Doyle E.M., Ellis P.A., Hoogasian J.J. Dietary n-3 fatty acid supplementation reduces superoxide production and chemiluminescence in a monocyte-enriched preparation of leukocytes. The American Journal of Clinical Nutrition 1990, 51(5):804-808. http://www.ncbi.nlm.nih.gov/pubmed/2159210.
17. Folch J., Lees M., Sloane Stanley G.H. A simple method for the isolation and purification of total lipides from animal tissues. The Journal of Biological Chemistry 1957, 226(1):497-509.
18. Giacobini E., Gold G. Alzheimer disease therapy - Moving from amyloid-beta to tau. Nature Reviews. Neurology 2013, 9(12):677-686. 10.1038/nrneurol.2013.223.
19. Gil A. Polyunsaturated fatty acids and inflammatory diseases. Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie 2002, 56(8):388-396. http://www.ncbi.nlm.nih.gov/pubmed/12442911.
20. Goldgaber D., Harris H.W., Hla T., Maciag T., Donnelly R.J., Jacobsen J.S., Vitek M.P., Gajdusek D.C. Interleukin 1 regulates synthesis of amyloid beta-protein precursor mRNA in human endothelial cells. Proceedings of the National Academy of Sciences of the United States of America 1989, 86(19):7606-7610. http://www.ncbi.nlm.nih.gov/pubmed/2508093.
21. Hamano H., Nabekura J., Nishikawa M., Ogawa T. Docosahexaenoic acid reduces GABA response in substantia nigra neuron of rat. Journal of Neurophysiology 1996, 75(3):1264-1270. http://www.ncbi.nlm.nih.gov/pubmed/8867135.
22. Harbige L.S. Fatty acids, the immune response, and autoimmunity: A question of n-6 essentiality and the balance between n-6 and n-3. Lipids 2003, 38(4):323-341. http://www.ncbi.nlm.nih.gov/pubmed/12848277.
23. Hardy J., Selkoe D.J. The amyloid hypothesis of Alzheimer's disease: Progress and problems on the road to therapeutics. Science 2002, 297(5580):353-356. 10.1126/science.1072994.
24. Hashimoto M., Hossain S., Shimada T., Sugioka K., Yamasaki H., Fujii Y., Ishibashi Y., Oka J., Shido O. Docosahexaenoic acid provides protection from impairment of learning ability in Alzheimer's disease model rats. Journal of Neurochemistry 2002, 81(5):1084-1091. http://www.ncbi.nlm.nih.gov/pubmed/12065621.
25. Hashimoto M., Hossain S., Tanabe Y., Kawashima A., Harada T., Yano T., Mizuguchi K., Shido O. The protective effect of dietary eicosapentaenoic acid against impairment of spatial cognition learning ability in rats infused with amyloid beta(1-40). The Journal of Nutritional Biochemistry 2009, 20(12):965-973. 10.1016/j.jnutbio.2008.08.009.
26. Hashimoto M., Tanabe Y., Fujii Y., Kikuta T., Shibata H., Shido O. Chronic administration of docosahexaenoic acid ameliorates the impairment of spatial cognition learning ability in amyloid beta-infused rats. The Journal of Nutrition 2005, 135(3):549-555. http://www.ncbi.nlm.nih.gov/pubmed/15735092.
27. Hashimoto M., Tozawa R., Katakura M., Shahdat H., Haque A.M., Tanabe Y., Gamoh S., Shido O. Protective effects of prescription n-3 fatty acids against impairment of spatial cognitive learning ability in amyloid beta-infused rats. Food & Function 2011, 2(7):386-394. 10.1039/c1fo00002k.
28. Hernandez F., Borrell J., Guaza C., Avila J., Lucas J.J. Spatial learning deficit in transgenic mice that conditionally over-express GSK-3beta in the brain but do not form tau filaments. Journal of Neurochemistry 2002, 83(6):1529-1533. http://www.ncbi.nlm.nih.gov/pubmed/12472906.
29. Hiratsuka S., Ishihara K., Kitagawa T., Wada S., Yokogoshi H. Effect of dietary docosahexaenoic acid connecting phospholipids on the lipid peroxidation of the brain in mice. Journal of Nutritional Science and Vitaminology 2008, 54(6):501-506. http://www.ncbi.nlm.nih.gov/pubmed/19155590.
30. Hiratsuka S., Koizumi K., Ooba T., Yokogoshi H. Effects of dietary docosahexaenoic acid connecting phospholipids on the learning ability and fatty acid composition of the brain. Journal of Nutritional Science and Vitaminology 2009, 55(4):374-380. http://www.ncbi.nlm.nih.gov/pubmed/19763040.
31. Hoshino T., Nakaya T., Homan T., Tanaka K., Sugimoto Y., Araki W., Narita M., Narumiya S., Suzuki T., Mizushima T. Involvement of prostaglandin E2 in production of amyloid-beta peptides both in vitro and in vivo. The Journal of Biological Chemistry 2007, 282(45):32676-32688. 10.1074/jbc.M703087200.
32. Kalmijn S., Launer L.J., Ott A., Witteman J.C., Hofman A., Breteler M.M. Dietary fat intake and the risk of incident dementia in the Rotterdam Study. Annals of Neurology 1997, 42(5):776-782. 10.1002/ana.410420514.
33. Konagai C., Yanagimoto K., Hayamizu K., Han L., Tsuji T., Koga Y. Effects of krill oil containing n-3 polyunsaturated fatty acids in phospholipid form on human brain function: A randomized controlled trial in healthy elderly volunteers. Clinical Interventions in Aging 2013, 8:1247-1257. 10.2147/CIA.S50349.
34. Le Grandois J., Marchioni E., Zhao M., Giuffrida F., Ennahar S., Bindler F. Investigation of natural phosphatidylcholine sources: Separation and identification by liquid chromatography-electrospray ionization-tandem mass spectrometry (LC-ESI-MS2) of molecular species. Journal of Agricultural and Food Chemistry 2009, 57(14):6014-6020. 10.1021/jf900903e.
35. Liu G., Wang T., Wang T., Song J., Zhou Z. Effects of apoptosis-related proteins caspase-3, Bax and Bcl-2 on cerebral ischemia rats. Biomedical Reports 2013, 1(6):861-867. 10.3892/br.2013.153.
36. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2-δδCT method. Methods (San Diego, Calif.) 2001, 25(4):402-408.
37. Lucas J.J., Hernandez F., Gomez-Ramos P., Moran M.A., Hen R., Avila J. Decreased nuclear beta-catenin, tau hyperphosphorylation and neurodegeneration in GSK-3beta conditional transgenic mice. The EMBO Journal 2001, 20(1-2):27-39. 10.1093/emboj/20.1.27.
38. Luchtman D.W., Meng Q., Song C. Ethyl-eicosapentaenoate (E-EPA) attenuates motor impairments and inflammation in the MPTP-probenecid mouse model of Parkinson's disease. Behavioural Brain Research 2012, 226(2):386-396. 10.1016/j.bbr.2011.09.033.
39. Ly P.T., Wu Y., Zou H., Wang R., Zhou W., Kinoshita A., Zhang M., Yang Y., Cai F., Woodgett J., Song W. Inhibition of GSK3beta-mediated BACE1 expression reduces Alzheimer-associated phenotypes. The Journal of Clinical Investigation 2013, 123(1):224-235. 10.1172/JCI64516.
40. Maki K.C., Reeves M.S., Farmer M., Griinari M., Berge K., Vik H., Hubacher R., Rains T.M. Krill oil supplementation increases plasma concentrations of eicosapentaenoic and docosahexaenoic acids in overweight and obese men and women. Nutrition Research 2009, 29(9):609-615. 10.1016/j.nutres.2009.09.004.
41. Montine T.J., Sidell K.R., Crews B.C., Markesbery W.R., Marnett L.J., Roberts L.J., Morrow J.D. Elevated CSF prostaglandin E2 levels in patients with probable AD. Neurology 1999, 53(7):1495-1498. http://www.ncbi.nlm.nih.gov/pubmed/10534257.
42. Mori T.A., Beilin L.J. Omega-3 fatty acids and inflammation. Current Atherosclerosis Reports 2004, 6(6):461-467. http://www.ncbi.nlm.nih.gov/pubmed/15485592.
43. Morris M.C., Evans D.A., Bienias J.L., Tangney C.C., Bennett D.A., Wilson R.S., Aggarwal N., Schneider J. Consumption of fish and n-3 fatty acids and risk of incident Alzheimer disease. Archives of Neurology 2003, 60(7):940-946. 10.1001/archneur.60.7.940.
44. Mrak R.E., Griffin W.S. Role of activated glia and of glial cytokines in Alzheimer's disease: A review. Eos 1996, 16(3-4):80-84. http://www.ncbi.nlm.nih.gov/pubmed/24478534.
45. Paxinos G., Watson C. The rat brain in stereotaxic coordinates 1986, Academic, New York.
46. Qu M.H., Yang X., Wang Y., Tang Q., Han H., Wang J., Wang G.D., Xue C., Gao Z. Docosahexaenoic acid-phosphatidylcholine improves cognitive deficits in an abeta23-35-induced Alzheimer's disease rat model. Current Topics in Medicinal Chemistry 2016, 16(5):558-564. http://www.ncbi.nlm.nih.gov/pubmed/26268328.
47. Ramprasath V.R., Eyal I., Zchut S., Jones P.J. Enhanced increase of omega-3 index in healthy individuals with response to 4-week n-3 fatty acid supplementation from krill oil versus fish oil. Lipids in Health and Disease 2013, 12:178. 10.1186/1476-511X-12-178.
48. Ramprasath V.R., Eyal I., Zchut S., Shafat I., Jones P.J. Supplementation of krill oil with high phospholipid content increases sum of EPA and DHA in erythrocytes compared with low phospholipid krill oil. Lipids in Health and Disease 2015, 14:142. 10.1186/s12944-015-0142-y.
49. Rapoport M., Dawson H.N., Binder L.I., Vitek M.P., Ferreira A. Tau is essential to beta -amyloid-induced neurotoxicity. Proceedings of the National Academy of Sciences of the United States of America 2002, 99(9):6364-6369. 10.1073/pnas.092136199.
50. Roberson E.D., Scearce-Levie K., Palop J.J., Yan F., Cheng I.H., Wu T., Gerstein H., Yu G.Q., Mucke L. Reducing endogenous tau ameliorates amyloid beta-induced deficits in an Alzheimer's disease mouse model. Science 2007, 316(5825):750-754. 10.1126/science.1141736.
51. Rossmeisl M., Jilkova Z.M., Kuda O., Jelenik T., Medrikova D., Stankova B., Kristinsson B., Haraldsson G.G., Svensen H., Stoknes I., Sjövall P., Magnusson Y., Balvers M.G., Verhoeckx K.C., Tvrzicka E., Bryhn M., Kopecky J. Metabolic effects of n-3 PUFA as phospholipids are superior to triglycerides in mice fed a high-fat diet: Possible role of endocannabinoids. PLoS ONE 2012, 7(6):e38834. 10.1371/journal.pone.0038834.
52. Saeki K., Machida M., Kinoshita Y., Takasawa R., Tanuma S. Glycogen synthase kinase-3beta2 has lower phosphorylation activity to tau than glycogen synthase kinase-3beta1. Biological and Pharmaceutical Bulletin 2011, 34(1):146-149. http://www.ncbi.nlm.nih.gov/pubmed/21212533.
53. Saito Y., Nishio K., Ogawa Y., Kinumi T., Yoshida Y., Masuo Y., Niki E. Molecular mechanisms of 6-hydroxydopamine-induced cytotoxicity in PC12 cells: Involvement of hydrogen peroxide-dependent and -independent action. Free Radical Biology & Medicine 2007, 42(5):675-685. 10.1016/j.freeradbiomed.2006.12.004.
54. Santacruz K., Lewis J., Spires T., Paulson J., Kotilinek L., Ingelsson M., Guimaraes A., DeTure M., Ramsden M., McGowan E., Forster C., Yue M., Orne J., Janus C., Mariash A., Kuskowski M., Hyman B., Hutton M., Ashe K.H. Tau suppression in a neurodegenerative mouse model improves memory function. Science 2005, 309(5733):476-481. 10.1126/science.1113694.
55. Simopoulos A.P. Omega-3 fatty acids in inflammation and autoimmune diseases. Journal of the American College of Nutrition 2002, 21(6):495-505. http://www.ncbi.nlm.nih.gov/pubmed/12480795.
56. Song C., Horrobin D. Omega-3 fatty acid ethyl-eicosapentaenoate, but not soybean oil, attenuates memory impairment induced by central IL-1beta administration. Journal of Lipid Research 2004, 45(6):1112-1121. 10.1194/jlr.M300526-JLR200.
57. Song J.H., Inoue Y., Miyazawa T. Oxidative stability of docosahexaenoic acid-containing oils in the form of phospholipids, triacylglycerols, and ethyl esters. Bioscience, Biotechnology, and Biochemistry 1997, 61(12):2085-2088. 10.1271/bbb.61.2085.
58. Song J.H., Miyazawa T. Superior oxidative stability of docosahexaenoic acid-enriched oils in the form of phospholipids. Journal of Food Lipids 1997, 4(2):109-117. 10.1271/bbb.61.2085.
59. Takahashi M., Tsuboyama-Kasaoka N., Nakatani T., Ishii M., Tsutsumi S., Aburatani H., Ezaki O. Fish oil feeding alters liver gene expressions to defend against PPARalpha activation and ROS production. American Journal of Physiology. Gastrointestinal and Liver Physiology 2002, 282(2):G338-G348. 10.1152/ajpgi.00376.2001.
60. Takeuchi M., Hara S., Totani Y., Hibino H., Tanaka Y. Autooxidative behavior of polyunsaturated phospholipids. I. Oxidative stability of marine oil containing polyunsaturated phospholipids. Journal of Japan Oil Chemists' Society 1997, 46:175-182. Cote INIST: 9018, 35400006490842.0060.
61. Tang X., Li Z.J., Xu J., Xue Y., Li J.Z., Wang J.F., Yanagita T., Xue C.H., Wang Y.M. Short term effects of different omega-3 fatty acid formulation on lipid metabolism in mice fed high or low fat diet. Lipids in Health and Disease 2012, 11:70. 10.1186/1476-511X-11-70.
62. Tou J.C., Jaczynski J., Chen Y.C. Krill for human consumption: Nutritional value and potential health benefits. Nutrition Reviews 2007, 65(2):63-77. http://www.ncbi.nlm.nih.gov/pubmed/17345959.
63. Trepanier M.O., Hopperton K.E., Orr S.K., Bazinet R.P. n-3 Polyunsaturated fatty acids in animal models with neuroinflammation: An update. European Journal of Pharmacology 2015, 10.1016/j.ejphar.2015.05.045.
64. Uemura K., Kuzuya A., Shimozono Y., Aoyagi N., Ando K., Shimohama S., Kinoshita A. GSK3beta activity modifies the localization and function of presenilin 1. The Journal of Biological Chemistry 2007, 282(21):15823-15832. 10.1074/jbc.M610708200.
65. Ulven S.M., Kirkhus B., Lamglait A., Basu S., Elind E., Haider T., Berge K., Vik H., Pedersen J.I. Metabolic effects of krill oil are essentially similar to those of fish oil but at lower dose of EPA and DHA, in healthy volunteers. Lipids 2011, 46(1):37-46. 10.1007/s11745-010-3490-4.
66. Vandenabeele P., Fiers W. Is amyloidogenesis during Alzheimer's disease due to an IL-1-/IL-6-mediated 'acute phase response' in the brain?. Immunology Today 1991, 12(7):217-219. 10.1016/0167-5699(91)90032-O.
67. Wang D.M., Li S.Q., Zhu X.Y., Wang Y., Wu W.L., Zhang X.J. Protective effects of hesperidin against amyloid-beta (Abeta) induced neurotoxicity through the voltage dependent anion channel 1 (VDAC1)-mediated mitochondrial apoptotic pathway in PC12 cells. Neurochemical Research 2013, 38(5):1034-1044. 10.1007/s11064-013-1013-4.
68. Wen M., Ding L., Zhang L., Zhou M., Xu J., Wang J., Wang Y., Xue C. DHA-PC and DHA-PS improved Aβ1-40 induced cognitive deficiency uncoupled with an increase in brain DHA in rats. Journal of Functional Foods 2016, 22:417-430. 10.1016/j.jff.2016.02.004.
69. Wu F.J., Xue Y., Liu X.F., Xue C.H., Wang J.F., Du L., Takahashi K., Wang Y.M. The protective effect of eicosapentaenoic acid-enriched phospholipids from sea cucumber Cucumaria frondosa on oxidative stress in PC12 cells and SAMP8 mice. Neurochemistry International 2014, 64:9-17. 10.1016/j.neuint.2013.10.015.